Pattern forming method and processing liquid for metal compound-containing film

A solvent-based treatment for metal compound-containing films addresses the challenges of pattern formation and etching resistance in semiconductor manufacturing by using specific polar substituents, enabling precise and stable pattern creation with EUV or electron beam lithography.

WO2024242120A1PCT designated stage expired Publication Date: 2024-11-28TOKYO OHKA KOGYO CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/018743
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-24
Filing Date
2024-05-21
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

The challenge in semiconductor device manufacturing is forming patterns smaller than the wavelength of ultraviolet light used in photolithography, which requires complex high-resolution techniques and results in high aspect ratio resist films prone to pattern collapse, especially when using EUV or electron beam lithography, where chemically amplified organic resists face absorption issues and etching resistance is inadequate with thin films.

Method used

A pattern forming method using a metal compound-containing film treated with a solvent mixture containing specific polar substituents, such as benzene rings and aromatic heterocycles, to selectively expose and develop the film, reducing particle numbers and enhancing etching resistance without increasing film thickness.

Benefits of technology

This method allows for precise pattern formation with improved etching resistance and reduced risk of pattern collapse, even with thin films, suitable for EUV or electron beam lithography, using a treatment liquid with a solvent composition that differentiates exposed and unexposed areas effectively.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JPOXMLDOC01-APPB-C000001
    Figure JPOXMLDOC01-APPB-C000001
  • Figure JPOXMLDOC01-APPB-C000002
    Figure JPOXMLDOC01-APPB-C000002
  • Figure JPOXMLDOC01-APPB-C000003
    Figure JPOXMLDOC01-APPB-C000003
Patent Text Reader

Abstract

Disclosed is a pattern forming method which includes a step for exposing a metal compound-containing film to light and a step for processing the light-exposed metal compound-containing film with use of a processing liquid, and which is characterized in that the processing liquid contains 20% by mass or more of a first solvent that is composed of one or more solvents selected from the group consisting of (1) a benzene ring in which one or more hydrogen atoms are each substituted by a polar substituent, (2) a 5- or 6-membered aromatic heterocyclic ring in which one or more hydrogen atoms may be each substituted by a polar substituent, (3) a 5- or 6-membered hydrocarbon ring which has one or more double bonds in the ring, and in which at least one hydrogen atom is substituted by a polar substituent, or alternatively, a 5- or 6-membered hydrocarbon ring which has a carbonyl group in the ring, and in which at least one hydrogen atom may be substituted by a polar substituent, and (4) a 5- or 6-membered non-aromatic heterocyclic ring in which at least one hydrogen atom is substituted by a polar substituent, or alternatively, a 5- or 6-membered non-aromatic heterocyclic ring which has a total of two or more of hetero atoms and / or carbonyl groups in the ring, and in which at least one hydrogen atom may be substituted by a polar substituent.
Need to check novelty before this filing date? Find Prior Art

Description

Pattern forming method and treatment solution for metal compound-containing film

[0001] The present invention relates to a pattern forming method and a treatment liquid for a metal compound-containing film.

[0002] The evolution of semiconductor device design to meet the need for improved semiconductor device performance has been achieved by shrinking feature sizes on semiconductor substrates. The rate of this technological progress is explained by the so-called "Moore's Law," which states that the density of transistors in high-density integrated circuits doubles every two years. In fact, the design and manufacturing of semiconductor device chips has advanced to the point where billions of transistors and circuits are formed on a single chip.

[0003] The size of individual structures on semiconductor device chips is approximately 22 nm or less, and in some cases, less than 10 nm. The photolithography process for forming these microstructures typically uses ultraviolet (UV) light with a wavelength of 193 nm for exposure. However, this light wavelength is already significantly larger than the desired pattern size to be formed on the semiconductor substrate. This creates various problems. For example, achieving pattern sizes smaller than the wavelength of light requires complex high-resolution techniques such as multi-patterning. Therefore, the development of lithography technologies using ultrashort wavelength light, such as extreme ultraviolet (EUV) light with a wavelength of approximately 10 to 15 nm (e.g., 13.5 nm), or particle beams such as electron beams (EB) is extremely important.

[0004] However, in photolithography processes using EUV, it is difficult to apply chemically amplified organic resists due to the absorption characteristics of the resist composition. Furthermore, in order to impart sufficient etching resistance to a patterned resist film formed using an organic resist, the resist film must be made thick. In this case, the patterned resist film has a high aspect ratio, which poses a high risk of pattern collapse. Given these circumstances, there is a need for a method for forming a resist film that can be well patterned using EUV (extreme ultraviolet) or electron beam lithography and that exhibits excellent etching resistance even at thin films.

[0005] In response to such demands, metal compound-containing resists using tin compounds or the like have been proposed (for example, Patent Documents 1 and 2).

[0006] US Patent No. 1,392,028 US Patent Application Publication No. 2021 / 026241

[0007] The present invention has been made in view of the above-described conventional circumstances, and an object of the present invention is to provide a method for forming a pattern of a metal compound-containing film, and a treatment liquid that can be suitably used in forming a pattern of a metal compound-containing film.

[0008] The present inventors have conducted extensive research to solve the above-mentioned problems, and as a result, have found that after exposing a metal compound-containing film, the unexposed portions of the metal compound-containing film can be selectively reduced and a pattern can be formed by using, as a first solvent, one or more solvents selected from the group consisting of: (1) a benzene ring in which one or more hydrogen atoms are substituted with a polar substituent; (2) a 5- or 6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent; (3) a 5- or 6-membered hydrocarbon ring having one or more double bonds in the ring and at least one hydrogen atom being substituted with a polar substituent, or having a carbonyl group in the ring and at least one hydrogen atom being substituted with a polar substituent; and (4) a 5- or 6-membered non-aromatic heterocycle in which at least one hydrogen atom is substituted with a polar substituent, or having a total of two or more heteroatoms or carbonyl groups in the ring and at least one hydrogen atom being substituted with a polar substituent. This finding led to the completion of the present invention.

[0009] That is, the present invention relates to the following inventions. [1] A pattern formation method comprising the steps of exposing a metal compound-containing film to light and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid contains 20% by mass or more of a first solvent that is one or more selected from the group consisting of: (1) a benzene ring in which one or more hydrogen atoms are substituted with a polar substituent; (2) a 5- or 6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent; (3) a 5- or 6-membered hydrocarbon ring having one or more double bonds in the ring and at least one hydrogen atom being substituted with a polar substituent, or having a carbonyl group in the ring and at least one hydrogen atom being substituted with a polar substituent; and (4) a 5- or 6-membered non-aromatic heterocycle in which at least one hydrogen atom is substituted with a polar substituent, or having a total of two or more heteroatoms or carbonyl groups in the ring and at least one hydrogen atom being substituted with a polar substituent. [2] A pattern formation method comprising the steps of forming a metal compound-containing film using a metal compound-containing film-forming composition, exposing the metal compound-containing film, and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid is selected from the group consisting of: (1) a benzene ring in which one or more hydrogen atoms are substituted with a polar substituent; (2) a 5- or 6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent; (3) a 5- or 6-membered hydrocarbon ring in which one or more double bonds are present in the ring and at least one hydrogen atom is substituted with a polar substituent, or a carbonyl group is present in the ring and at least one hydrogen atom is substituted with a polar substituent; and (4) a 5- or 6-membered non-aromatic heterocycle in which at least one hydrogen atom is substituted with a polar substituent, or ... [3] The pattern formation method according to [1], wherein the treatment liquid further contains 1 to 80 mass % of a second solvent different from the first solvent.[4] The pattern formation method according to [3], wherein the second solvent is one or more solvents selected from the group consisting of ketone-based solvents, ester-based solvents, alcohol-based solvents, amide-based solvents, ether-based solvents, hydrocarbon-based solvents, and water. [5] The pattern formation method according to [1], wherein the metal compound-containing film is a metal compound-containing film containing a metal element of Groups 3 to 7. [6] The pattern formation method according to [1], wherein the metal compound is a polyoxometalate. [7] The pattern formation method according to [6], wherein the polyoxometalate is a polyoxomolybdate, polyoxotungstate, polyoxovanadate, polyoxoniobate, or polyoxotantalate. [8] The pattern formation method according to [6], wherein the polyoxometalate is an onium salt. [9] The pattern formation method according to [8], wherein the onium salt is an ammonium salt, a sulfonium salt, or an iodonium salt.

[10] The pattern formation method according to [1], wherein the exposing step is a step of exposing with EUV or an electron beam.

[11] A treatment solution for a metal compound-containing film, comprising 20 mass % or more of a first solvent selected from the group consisting of: (1) a benzene ring in which one or more hydrogen atoms are substituted with a polar substituent, (2) a 5- or 6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent, (3) a 5- or 6-membered hydrocarbon ring having one or more double bonds within the ring and at least one hydrogen atom being substituted with a polar substituent, or having a carbonyl group within the ring and at least one hydrogen atom being substituted with a polar substituent, and (4) a 5- or 6-membered non-aromatic heterocycle in which at least one hydrogen atom is substituted with a polar substituent, or having a total of two or more heteroatoms or carbonyl groups within the ring and at least one hydrogen atom being substituted with a polar substituent.

[12] The metal compound-containing film treatment solution according to

[11] , further comprising 1 to 80 mass % of a second solvent different from the first solvent.

[13] The metal compound-containing film treatment solution according to

[12] , wherein the second solvent is one or more solvents selected from the group consisting of ketone-based solvents, ester-based solvents, alcohol-based solvents, amide-based solvents, ether-based solvents, hydrocarbon-based solvents, and water.

[14] The metal compound-containing film treatment liquid according to

[11] , which is a polyoxometalate-containing film treatment liquid.

[0010] The present invention provides a method for forming a pattern of a metal compound-containing film and a treatment liquid suitable for use in forming a pattern of a metal compound-containing film. Furthermore, the treatment liquid according to the present invention can selectively reduce the film thickness in unexposed areas of a metal compound-containing film, and is therefore suitable for use as a treatment liquid for metal compound films, particularly as a treatment liquid for polyoxometalate-containing films.

[0011] Preferred embodiments of the present invention will be described in detail below, but the present invention is not limited to the following embodiments.

[0012] [1. Pattern Forming Method] The pattern forming method according to this embodiment includes the steps of forming a metal compound-containing film on a substrate using a metal compound-containing film-forming composition, exposing the metal compound-containing film to light, and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid contains 20 mass % or more of a first solvent that is any one of the following (1) to (4): (1) A benzene ring in which one or more hydrogen atoms are substituted with a polar substituent. (2) A five- or six-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent. (3) A five- or six-membered hydrocarbon ring having one or more double bonds in the ring and at least one or more hydrogen atoms substituted with a polar substituent, or having a carbonyl group in the ring and at least one or more hydrogen atoms may be substituted with a polar substituent. (4) A five- or six-membered non-aromatic heterocycle in which at least one hydrogen atom is substituted with a polar substituent, or having two or more heteroatoms or carbonyl groups in total in the ring and at least one hydrogen atom may be substituted with a polar substituent.

[0013] [1-1. Metal Compound-Containing Film-Forming Composition] The metal compound-containing film-forming composition according to this embodiment contains a metal compound. The metal compound is not particularly limited, and examples of the metal compound include metal atoms or metal ions of metal elements in Groups 3 to 16 of the long-form periodic table, metal oxides of the metal atoms or metal ions, and compounds containing bonds that bond to the metal atoms, metal ions, or metal oxides via ionic, coordinate, or covalent bonds.

[0014] [1-1-1. Metal Compound] <Metal Element> As the metal element contained in the metal compound, metal elements of Groups 3 to 16 of the long-form periodic table can be used. Examples of metal elements of Groups 3 to 16 of the long-form periodic table include metal elements of Group 3 such as scandium (Sc), yttrium (Y), lanthanum (La), and cerium (Ce); metal elements of Group 4 such as titanium (Ti), zirconium (Zr), and hafnium (Hf); metal elements of Group 5 such as vanadium (V), niobium (Nb), and tantalum (Ta); metal elements of Group 6 such as chromium (Cr), molybdenum (Mo), and tungsten (W); metal elements of Group 7 such as manganese (Mn) and rhenium (Re); metal elements of Group 8 such as iron (Fe), ruthenium (Ru), and osmium (Os); cobalt (Co), ruthenium (Ru), and ruthenium (Ru). Examples of metal elements include Group 9 metal elements such as rhenium (Rh) and iridium (Ir); Group 10 metal elements such as nickel (Ni), palladium (Pd), and platinum (Pt); Group 11 metal elements such as copper (Cu), silver (Ag), and gold (Au); Group 12 metal elements such as zinc (Zn), cadmium (Cd), and mercury (Hg); Group 13 metal elements such as aluminum (Al), gallium (Ga), indium (In), and thallium (Tl); Group 14 metal elements such as germanium (Ge), tin (Sn), and lead (Pb); Group 15 metal elements such as antimony (Sb) and bismuth (Bi); and Group 16 metal elements such as tellurium (Te). The metal compound may contain one of the above metal elements alone, or two or more of them may be combined.

[0015] Among the above metal elements, it is preferable to use metal elements from Groups 3 to 16 in the fourth to sixth periods as the metal element contained in the metal compound. While tin compounds and the like can be suitably used as the metal compound, problems may arise with tin compounds, such as contamination of equipment due to residues generated during coating processing and the toxicity of the tin compounds themselves. Therefore, among the above metal elements, it is more preferable to use metal elements from Groups 3 to 7 as the metal compound, and it is even more preferable to use metal elements from Groups 3 to 7 in the fourth to sixth periods.

[0016] <Metal Oxide> The metal oxide of the metal atom or metal ion of the above metal element is not particularly limited, and known and commonly used materials can be used. Examples of the metal oxide include scandium oxide (Sc 2 O 3 ), yttrium oxide (Y 2 O 3 ), titanium oxide (TiO 2 ), zirconium oxide (ZrO 2 ), hafnium oxide (HfO 2 ), vanadium oxide (V 2 O 5 ), niobium oxide (Nb 2 O 5 ), tantalum oxide (Ta 2 O 5 ), chromium oxide (CrO 3 ), molybdenum oxide (MoO 3 ), tungsten oxide (WO 3 ), aluminum oxide (Al 2 O 3 ), gallium oxide (Ga 2 O 3 ), indium oxide (In 2 O 3 ), germanium dioxide (GaO 2 ), tin oxide (SnO), antimony trioxide (Sb 2 O 3 ) etc. can be used.

[0017] (Polyoxometalate) As the metal oxide, polyoxometalate (polyacid salt) can be suitably used. x O y ] n- (wherein x, y, and n are all natural numbers). The metal atom M constituting the polyoxometalate is called a polyatom, and examples thereof include Mo (hexavalent or pentavalent), W (hexavalent or pentavalent), V (pentavalent), Nb (pentavalent), and Ta (pentavalent). Polyoxometalates include isopolyoxometalates composed of the polyatom M and an oxyacid, and polyoxometalates containing different types of atoms X (for example, heteroatoms X such as P 5+ , Si 4+ , Ge 4+ , B 3+ Heteropolyoxometalates ([X w M x O y ] n- (wherein w, x, y, and n are all natural numbers)

[0018] Examples of isopolyoxometalates include salts of isopolyoxomolybdic acid, isopolyoxotungstic acid, isopolyoxovanadic acid, isopolyoxoniobic acid, and isopolyoxotantalic acid. Examples of the isopolyoxomolybdic acid include, for example, [MoO 4 ] 2- , [Mo 7 O 24 ] 6- , [Mo 8 O 26 ] 4- Examples of the isopolyoxotungstic acid include [W 4 O 13 ] 2- , [W 5 O 16 ] 2- , [W 6 O 19 ] 2- , [W 7 O 22 ] 2- , [W7 O 24 ] 6- , [H z W 12 O 40 ] -(8-z) (wherein z represents an integer of 1 to 4), [W 10 O 32 ] 4- , [H 4 W 11 O 38 ] 6- , [H 7 W 11 O 40 ] 7- , [HW 5 O 19 ] 7- , [H 3 W 11 O 22 ] 5- Examples of the isopolyoxovanadic acid include [V 4 O 12 ] 4- , [V 10 O 28 ] 6- The isopolyoxoniobic acid may, for example, be [Nb 6 O 19 ] 8- , [Nb 10 O 28 ] 6- Examples of the isopolyoxotantalic acid include [Ta 6 O 19 ] 8- , [Ta 8 O 21 ] 2- The above-mentioned isopolyoxomolybdic acid, isopolyoxotungstic acid, isopolyoxovanadic acid, isopolyoxoniobic acid, and isopolyoxotantalic acid include various isomers.

[0019] Examples of heteropolyoxometalates include salts of heteropolyoxomolybdic acid, heteropolyoxotungstic acid, heteropolyoxovanadic acid, heteropolyoxoniobic acid, and heteropolyoxotantalic acid. Examples of heteropolyoxomolybdic acids include phosphomolybdic acid, silicomolybdic acid, boromolybdic acid, phosphotungstomolybdic acid, cobaltomolybdic acid, arsenic molybdic acid, and germanomolybdic acid. Examples of heteropolyoxotungstic acids include phosphotungstic acid, silicotungstic acid, borotungstic acid, cobaltotungstic acid, arsenic tungstic acid, and germanotungstic acid. Examples of the heteropolyoxovanadic acid include phosphomolybdovanadic acid, phosphomolybdotungstomolybdic acid, boromolybdovanadic acid, boromolybdotungstovanadic acid, etc. The heteropolyoxomolybdic acid, heteropolyoxotungstic acid, heteropolyoxovanadic acid, etc. include Keggin type, Dawson type, Anderson type, and defect species and isomers thereof.

[0020] The type of salt of a polyacid salt (isopolyoxometalate or heteropolyoxometalate) is not particularly limited, and may be a salt with a proton, an onium cation (e.g., an organic onium cation, an organic sulfonium cation, an organic iodonium cation, an organic quaternary ammonium cation, an organic phosphonium cation, etc.), an alkali metal ion, etc. From the viewpoint of improving actinic ray sensitivity or radiation sensitivity and varying the solvent solubility of exposed and unexposed areas, the type of salt of a polyacid salt is preferably a salt with an onium cation, and among these, a salt with an organic sulfonium cation, an organic iodonium cation, or an organic quaternary ammonium cation is more preferred.

[0021] The organic sulfonium cation is not particularly limited, and any known and commonly used organic sulfonium cation can be used. Examples of the organic sulfonium cation include organic sulfonium cations represented by formula (I):

[0022]

[0023] In formula (I), R 1A , R 1B and R 1C are each independently C 1-18 represents a hydrocarbyl group, a 3- to 18-membered non-aromatic heterocyclic group, or a 5- to 18-membered aromatic heterocyclic group, 1A , R 1B and R 1C The divalent carbon atom at any position excluding the terminal may be -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S- or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 1A , R 1B and R 1C The hydrogen atoms contained in the formula (I) are, for example, (a) halogen atoms, (b) haloalkyl groups, (c) hydroxy groups, (d) thiol groups, (e) nitro groups, (f) cyano groups, (g) carboxy groups, (h) amino groups, (i) sulfo groups, (j) hydroxy groups or carboxy groups having a protecting group, or (k) C groups in which at least a part of the hydrogen atoms may be substituted with the above (a) to (j). 1-18 Hydrocarbyl group, C 1-18 Hydrocarbyloxy group, C 1-18 Hydrocarbyl carbonyl group, C 1-18 Hydrocarbylcarbonyloxy group, C 1-18 Hydrocarbyloxycarbonyl group, C 1-18 a hydrocarbyloxycarbonyloxy group, or C 1-18 In a hydrocarbylthio group, the divalent carbon atom at any position except at the terminal of these substituents is -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S-, or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 1A , R 1B and R 1CAny two of these are directly connected to each other by a single bond, or are divalent linking groups -O-, -S-, -C(=O)-, -S(=O)-, -S(=O) 2 -, -C(=O)O-, or C 1-3 They may be linked via an alkylene group to form a ring together with the sulfur atom in formula (I).

[0024] R in formula (I) 1A , R 1B and R 1C Each of the C groups independently has a substituent. 6-18 It is preferably an aryl group. 6-18 The substituent of the aryl group may be a halogen atom, a haloalkyl group, a hydroxy group, a nitro group, a cyano group, a C 1-12 A hydrocarbylthio group is preferred, a halogen atom, C 1-4 A haloalkyl group or a nitro group is more preferred.

[0025] Specific examples of the organic sulfonium cation include dibutyl(pentyl)sulfonium cation, triethylsulfonium cation, (2-carboxyethyl)dimethylsulfonium cation, trimethylsulfonium cation, dimethylphenacylsulfonium cation, 1-(4-hydroxynaphthalen-1-yl)hexahydrothiopyrylium cation, dimethylphenylsulfonium cation, triphenylsulfonium cation, tris(4-methylphenyl)sulfonium cation, 4-methoxyphenyldiphenylsulfonium cation, 4-iodophenyldiphenylsulfonium cation, tris(4-fluorophenyl)sulfonium cation, 1-phenylhexahydrothiopyrylium cation, (ethane-1,2-diylbisoxy)bis(4,1-phenylene)bis(diphenylsulfonium) dication, (thiodi-4,1-phenylene)bis(diphenylsulfonium) dication, di(naphthalen-1-yl)(fluorophenyl)sulfonium cation, and di(naphthalen-1-yl)(fluorophenyl)sulfonium cation. phenyl)sulfonium cation, phenylbis(2-(trifluoromethyl)phenyl)sulfonium cation, mesitylbis(2-(trifluoromethyl)phenyl)sulfonium cation, bis(3,5-difluorophenyl)(phenyl)sulfonium cation, tris(3,5-difluorophenyl)sulfonium cation, (4-(dodecanoyloxy-3,5-dimethylphenyl))diphenylsulfonium cation, diphenyl(3-(trifluoromethoxy)phenyl)sulfonium cation, (4-(1-adamantylcarbonyloxy)phenyl)diphenylsulfonium cation, (4-phenylthiophenyl)diphenylsulfonium cation, 5-phenyl-5H-thianthren-5-ium cation, 5-(2,5-dimethylphenyl)thianthren-5-ium cation, 5-phenyl-5H-dibenzo[b,d]thiophen-5-ium cation 5-(3-(trifluoromethyl)phenyl)-5H-dibenzo[b,Examples of the thiophene-5-ium cation include 1-(4-(t-butyl)phenyl)-1H-benzo[b]thiophen-1-ium cation, methyldiphenylsulfonium cation, (2-bromoethyl)diphenylsulfonium cation, (3-chloropropyl)diphenylsulfonium cation, benzyl(4-hydroxyphenyl)methylsulfonium cation, (4-hydroxyphenyl)methyl(2-methylbenzyl)sulfonium cation, 4-hydroxyphenyldimethylsulfonium cation, diphenyl(methyl)sulfonium cation, diphenyl(4-(phenylthio)phenyl)sulfonium cation, (2-bromoethyl)diphenylsulfonium cation, dimesityl(trifluoromethyl)sulfonium cation, and tri-p-tolyl sulfonium cation.

[0026] The organic iodonium cation is not particularly limited, and any known and commonly used organic iodonium cation can be used. Examples of the organic iodonium cation include organic iodonium cations represented by formula (II):

[0027]

[0028] In formula (II), R 2A and R 2B are each independently C 1-18 represents a hydrocarbyl group, a 3- to 18-membered non-aromatic heterocyclic group, or a 5- to 18-membered aromatic heterocyclic group, 2A and R 2B The divalent carbon atom at any position excluding the terminal may be -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S- or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 2A and R 2BThe hydrogen atoms contained in the formula (I) are, for example, (a) halogen atoms, (b) haloalkyl groups, (c) hydroxy groups, (d) thiol groups, (e) nitro groups, (f) cyano groups, (g) carboxy groups, (h) amino groups, (i) sulfo groups, (j) hydroxy groups or carboxy groups having a protecting group, or (k) C groups in which at least a part of the hydrogen atoms may be substituted with the above (a) to (j). 1-18 Hydrocarbyl group, C 1-18 Hydrocarbyloxy group, C 1-18 Hydrocarbyl carbonyl group, C 1-18 Hydrocarbylcarbonyloxy group, C 1-18 a hydrocarbyloxycarbonyl group, or C 1-18 A hydrocarbyloxycarbonyloxy group in which a divalent carbon atom at any position except the terminal of these substituents is -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S-, or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 2A and R 2B are directly connected to each other by a single bond, or are connected to each other by a divalent linking group, -O-, -S-, -C(=O)-, -S(=O)-, -S(=O) 2 -, -C(=O)O-, or C 1-3 They may be linked via an alkylene group to form a ring together with the iodine atom in formula (II).

[0029] R in formula (II) 2A and R 2B Each of the C groups independently has a substituent. 6-18 It is preferably an aryl group. 6-18 The substituent of the aryl group may be a halogen atom, a haloalkyl group, a hydroxy group, a nitro group, a cyano group, a C 1-12 Hydrocarbyl group, C 1-12 Hydrocarbyloxy group, C 1-12 Hydrocarbyl carbonyl group, C 1-12 Hydrocarbylcarbonyloxy group, C 1-12a hydrocarbyloxycarbonyl group, or C 1-12 A hydrocarbyloxycarbonyloxy group is preferred, and a halogen atom, C 1-4 Haloalkyl group, nitro group, C 1-8 Hydrocarbyl group, C 1-8 It is preferably a hydrocarbyloxy group.

[0030] Specific examples of the organic iodonium cation include ethynyl(phenyl)iodonium cation, bis(pyridine)iodonium cation, bis(2,4,6-trimethylpyridine)iodonium cation, diphenyliodonium cation, bis(4-(t-butyl)phenyl)iodonium cation, (2-carboxyphenyl)(phenyl)iodonium cation, (4-nitrophenyl)(phenyl)iodonium cation, (3-(trifluoromethyl)phenyl)(2,4,6-trimethylphenyl)iodonium cation, bis(4-fluorophenyl)iodonium cation, (4-(bromomethyl)phenyl)(2,4,6-trimethoxyphenyl)iodonium cation, 4-biphenylyl(2,4,6-trimethoxyphenyl)iodonium cation, bis(2,4,6-trimethylphenyl)iodonium cation, 4-isopropyl-4'-methyldiphenyliodonium cation, Examples of iodonium cation include (4-(trifluoromethyl)phenyl)(2,4,6-trimethylphenyl)iodonium cation, ((4-trifluoromethyl)phenyl)(2,4,6-trimethoxyphenyl)iodonium cation, (5-fluoro-2-nitrophenyl)(2,4,6-trimethoxyphenyl)iodonium cation, (3-bromophenyl)(mesityl)iodonium cation, bis(4-bromophenyl)iodonium cation, (3,5-dichlorophenyl)(2,4,6-trimethoxyphenyl)iodonium cation, (4-methylphenyl)(2,4,6-trimethylphenyl)iodonium cation, (3-methylphenyl)(2,4,6-trimethylphenyl)iodonium cation, (2-methylphenyl)(2,4,6-trimethylphenyl)iodonium cation, and phenyl(2,4,6-trimethoxyphenyl)iodonium cation.

[0031] The organic quaternary ammonium cation is not particularly limited, and any known or commonly used organic quaternary ammonium cation can be used. Examples of the organic quaternary ammonium cation include organic quaternary ammonium cations represented by formula (III):

[0032]

[0033] In formula (III), R 3A , R 3B , R 3C and R 3D are each independently C 1-18 represents a hydrocarbyl group, a 3- to 18-membered non-aromatic heterocyclic group, or a 5- to 18-membered aromatic heterocyclic group, 3A , R 3B , R 3C and R 3D The divalent carbon atom at any position excluding the terminal may be -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S- or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 3A , R 3B , R 3C and R 3D The hydrogen atoms contained in the formula (I) are, for example, (a) halogen atoms, (b) haloalkyl groups, (c) hydroxy groups, (d) thiol groups, (e) nitro groups, (f) cyano groups, (g) carboxy groups, (h) amino groups, (i) sulfo groups, (j) hydroxy groups or carboxy groups having a protecting group, or (k) C groups in which at least a part of the hydrogen atoms may be substituted with the above (a) to (j). 1-18 Hydrocarbyl group, C 1-18 Hydrocarbyloxy group, C 1-18 Hydrocarbyl carbonyl group, C 1-18 Hydrocarbylcarbonyloxy group, C 1-18 Hydrocarbyloxycarbonyl group, C 1-18 a hydrocarbyloxycarbonyloxy group, or C 1-18In a hydrocarbylthio group, the divalent carbon atom at any position except at the terminal of these substituents is -O-, -C(=O)-, -C(=O)O-, -OCO-, -CONH-, -NHCO-, -NH(C=O)O-, -S-, or -SO 2 - (provided that adjacent divalent carbon atoms are not simultaneously replaced); 3A , R 3B , R 3C and R 3D Any two of these are directly connected to each other by a single bond, or are divalent linking groups -O-, -S-, -C(=O)-, -S(=O)-, -S(=O) 2 -, -C(=O)O-, or C 1-3 They may be linked via an alkylene group to form a ring together with the nitrogen atom in formula (III).

[0034] R in formula (III) 3A , R 3B , R 3C and R 3D Each of the C groups independently has a substituent. 1-18 Preferably it is a hydrocarbyl group, C 1-12 Alkyl group, C 1-12 Alkenyl group, C 1-12 Alkynyl group, C 1-12 An alicyclic group is more preferred.

[0035] Specific examples of the organic quaternary ammonium cation include tetramethylammonium cation, tetraethylammonium cation, tetrapropylammonium cation, tetrabutylammonium cation, tetraheptylammonium cation, trimethylethylammonium cation, dimethyldiethylammonium cation, dimethylethylpropylammonium cation, methylethylpropylbutylammonium cation, trimethylphenylammonium cation, triethylhexylammonium cation, triethylcyclohexylammonium cation, and dodecyltrimethylammonium cation.

[0036] Polyacid salts are characterized by high thermal stability, oxidation resistance, high acid strength and oxidizing power, and reversible multi-electron redox ability, and examples of the synthesis and use of actinic ray-sensitive and radiation-sensitive polyoxometalates have been reported (e.g., JP-A-63-113452, JP-A-59-154089, JP-A-58-180400, etc.). However, because polyacid salts are salts of anionic polynuclear metal oxoclusters, they have poor solvent solubility, and it has been difficult to achieve a difference in solubility between areas exposed to actinic ray or radiation and areas not exposed to radiation. However, with the treatment liquid according to the present embodiment described below, it is possible to form a good pattern even when a polyacid salt is contained as the metal compound in the metal compound-containing film-forming composition.

[0037] In the metal compound-containing film-forming composition according to this embodiment, the content of the metal compound is not particularly limited and can be appropriately selected depending on the type of metal compound, the application, etc. The content of the metal compound in the metal compound-containing film-forming composition is preferably 0.5 to 20 parts by mass, more preferably 1 to 20 parts by mass, and even more preferably 1 to 10 parts by mass, based on 100 parts by mass of the metal compound-containing film-forming composition.

[0038] [1-1-2. Others] The metal compound-containing film-forming composition may contain organic solvents, inorganic fillers, quenchers, leveling agents, surfactants, and the like, as needed.

[0039] The organic solvent is not particularly limited as long as it can dissolve the metal compound and form a metal compound-containing film on the substrate. Examples of the organic solvent include halogenated hydrocarbons such as dichloromethane and 1,2-dichloroethane; alcohols such as methanol, ethanol, isopropanol, tert-butanol, 2-methyl-2-butanol, 4-methyl-2-pentanol, and diacetone alcohol; ethers such as propylene glycol monomethyl ether (PGME), diethyl ether, tetrahydrofuran, and 1,4-dioxane; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, 2-heptanone, and cyclohexanone; ethyl acetate, acetic acid, and the like. Examples of organic solvents include esters such as n-butyl acetate, propylene glycol monomethyl ether acetate (PGMEA), ethyl lactate (EL), hydroxyisobutyrate methyl ester, and ethyl acetoacetate; lactones such as γ-butyrolactone (GBL) and ε-caprolactone; lactams such as N-methylpyrrolidone, nitriles such as acetonitrile and propionitrile; cyclic or acyclic carbonates such as dimethyl carbonate, ethylene carbonate, propylene carbonate, and diphenyl carbonate; polar aprotic solvents such as dimethyl sulfoxide and dimethylformamide; and water. These organic solvents may be used alone or in combination of two or more. The organic solvent contained in the metal compound-containing film-forming composition according to this embodiment is preferably PGME, PGMEA, EL, GBL, methanol, water, or a combination thereof.

[0040] [1-2. Metal Compound-Containing Film Forming Step] The pattern forming method according to this embodiment includes a step of forming a metal compound-containing film on a substrate using a metal compound-containing film-forming composition.

[0041] <Substrate> The substrate used in this embodiment is not particularly limited, and a known and commonly used one can be used, for example, a substrate for electronic components, a substrate on which a predetermined wiring pattern is formed, etc. The material of the substrate is not particularly limited, and examples thereof include a silicon wafer, a substrate made of a metal such as copper, chromium, iron, or aluminum, and a substrate made of an inorganic material such as glass, titanium oxide, or silicon dioxide.

[0042] The size, shape, etc. of the substrate are not particularly limited, and the surface of the substrate may be smooth, curved, or uneven, or may be a thin plate-shaped substrate.

[0043] The surface of the substrate may be subjected to a surface treatment as necessary. In the case of a substrate having hydroxyl groups on its surface layer, the surface of the substrate is treated with a silane coupling agent capable of reacting with the hydroxyl groups, thereby changing the surface layer of the substrate from hydrophilic to hydrophobic, thereby improving the adhesion between the substrate and the metal compound-containing film. Examples of the silane coupling agent include hexamethyldisilazane (HMDS).

[0044] <Film formation method> The method for forming a metal compound-containing film on a substrate is not particularly limited, and any known or commonly used method can be used. As the film formation method, for example, a CVD method (chemical vapor deposition method) such as thermal CVD, plasma CVD, or photo CVD; a PVD method (physical vapor deposition method) such as vacuum deposition, plasma-assisted deposition, sputtering, or ion plating can be used as a dry method. Furthermore, for example, a coating method such as spin coating, bar coating, roll coating, flow coating, dip coating, spray coating, or screen printing can be used as a wet method.

[0045] As a method for forming a metal compound-containing film on a substrate using the metal compound-containing film-forming composition according to this embodiment, from the viewpoint of forming a uniform film thickness, etc., it is preferable to use a wet method such as spin coating or screen printing, and it is more preferable to use spin coating.

[0046] The method for drying the metal compound-containing film after it has been formed on the substrate is not particularly limited, and can be performed using, for example, a heating device such as a hot plate (post-applied bake (PAB)), a pressure reducing device, or the like. The baking conditions are not particularly limited, and can be set appropriately depending on the type and application of the metal compound-containing film. The baking temperature is preferably 100 to 300°C, more preferably 150 to 250°C, and even more preferably 170 to 230°C. The baking time is preferably 10 to 300 seconds, more preferably 20 to 180 seconds, and even more preferably 30 to 120 seconds.

[0047] The thickness of the metal compound-containing film after drying is not particularly limited, but is preferably 0.5 to 100 nm, more preferably 1 to 75 nm, and even more preferably 1 to 60 nm.

[0048] [1-3. Exposure Step of Metal Compound-Containing Film] The pattern formation method according to this embodiment includes a step of exposing the formed metal compound-containing film to light.

[0049] In the exposure step of the metal compound-containing film, an exposure device that can be used is an ArF exposure device, an electron beam lithography device, an EUV exposure device, etc. In the exposure step, exposure may be performed through a mask (mask pattern) on which a predetermined pattern is formed, or selective exposure may be performed by lithography using direct irradiation with an electron beam without using a mask pattern.

[0050] The wavelength used for exposure is not particularly limited, and examples thereof include ArF excimer laser (wavelength 193 nm), KrF excimer laser (248 nm), F 2 Radiation such as excimer laser (wavelength 157 nm), EUV (extreme ultraviolet), VUV (vacuum ultraviolet), EB (electron beam), X-ray, or soft X-ray may also be used.

[0051] The exposure dose on the metal compound-containing film is 1 to 100 mJ / cm in the case of an ArF excimer laser or a KrF excimer laser. 2 is preferably 20 to 60 mJ / cm 2In the case of extreme ultraviolet rays, the exposure dose is preferably 0.1 to 20 mJ / cm. 2 is preferably 3 to 15 mJ / cm 2 In the case of an electron beam, it is more preferable that the concentration is 3 μC / cm at 50 kV. 2 ~2mC / cm 2 It is preferable to expose with a dose of 10 μC / cm 2 ~1.5mC / cm 2 It is preferred to expose at a dose of 1000 ppm.

[0052] After the metal compound-containing film is exposed to light, it may be subjected to baking (post-exposure bake (PEB)). The baking conditions are not particularly limited and can be set appropriately depending on the type of metal compound-containing film, its intended use, and the like. The baking temperature is preferably 120 to 300°C, more preferably 150 to 250°C, and even more preferably 170 to 230°C, using a heating device such as a hot plate. The baking time is preferably 10 to 300 seconds, more preferably 20 to 180 seconds, and even more preferably 30 to 120 seconds.

[0053] [1-4. Treatment Step Using Treatment Liquid] The pattern formation method according to this embodiment includes a step of treating the exposed metal compound-containing film with a treatment liquid.

[0054] [1-4-1. Treatment Liquid] The meanings of terms, symbols, etc. used in this specification will be explained below, and embodiments of the present invention will be described in more detail.

[0055] In this specification, for example, "C 1-4 " and other terms refer to the number of carbon atoms in the core group.

[0056] As used herein, "C 1-4 The term "alkyl group" means a linear or branched alkyl group having 1 to 4 carbon atoms. 1-4 The "alkyl group" is not particularly limited, and examples thereof include a methyl group, an ethyl group, an n-propyl group, an i-propyl group, an n-butyl group, an i-butyl group, a sec-butyl group, and a t-butyl group.

[0057] As used herein, "C 2-4 The term "alkenyl group" refers to a group having two or more carbon atoms. 1-4 "C" means an alkenyl group having one double bond in the "alkyl group." 2-4 The "alkenyl group" is not particularly limited, and examples thereof include a vinyl group (ethenyl group), an allyl group (2-propenyl group), a 1-propenyl group, an isopropenyl group (1-methylvinyl group), a 1-butenyl group, a 2-butenyl group, and a 3-butenyl group.

[0058] As used herein, "C 2-4 The term "alkynyl group" refers to a group having two or more carbon atoms. 1-4 "C" means an alkynyl group having one triple bond in the "alkyl group." 2-4 The "alkynyl group" is not particularly limited, and examples thereof include an ethynyl group, a 1-propynyl group, and a 2-propynyl group.

[0059] As used herein, "C 3-4 The term "alicyclic group" means a cyclic hydrocarbon group having 3 to 4 carbon atoms. Alicyclic groups include cycloalkyl groups, cycloalkenyl groups, etc. 3-4 The "alicyclic group" is not particularly limited, and examples thereof include a cyclopropyl group and a cyclobutyl group.

[0060] As used herein, the term "5- or 6-membered aromatic heterocycle" refers to a monocyclic 5- or 6-membered aromatic heterocycle containing one or more heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom, and an oxygen atom. The "5- or 6-membered aromatic heterocycle" is not particularly limited, and examples thereof include 5-membered aromatic heterocycles such as pyrrole, pyrazole, imidazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, furan, thiophene, oxazole, isoxazole, isothiazole, thiazole, 1,2,5-oxadiazole, 1,2,3-oxadiazole, 1,3,4-thiadiazole, and 1,2,5-thiadiazole; and 6-membered aromatic heterocycles such as pyridine, pyridazine, pyrimidine, 1,2,4-triazine, and 1,3,5-triazine.

[0061] As used herein, a "five- or six-membered hydrocarbon ring" refers to a cyclic hydrocarbon group having 5 or 6 carbon atoms, and may be saturated or unsaturated. Furthermore, a divalent carbon atom at any position of the "five- or six-membered hydrocarbon ring" may be replaced with -(C=O)- (provided that adjacent divalent carbon atoms are not simultaneously replaced). The "five- or six-membered hydrocarbon ring" is not particularly limited, and examples thereof include cyclopentane, cyclopentene, cyclopentanone, cyclohexane, cyclohexene, and cyclohexanone.

[0062] As used herein, the term "5- or 6-membered non-aromatic heterocycle" refers to a 5- or 6-membered non-aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur atoms, and may be saturated or partially unsaturated. Furthermore, a divalent carbon atom at any position in the "5- or 6-membered non-aromatic heterocycle" may be replaced with -(C=O)- (provided that adjacent divalent carbon atoms are not replaced at the same time). The "5- or 6-membered non-aromatic heterocyclic group" is not particularly limited, and examples thereof include 5-membered non-aromatic heterocycles such as pyrrolidine, 3-pyrroline, pyrazolidine, imidazolidine, 2-pyrazoline, 2-imidazoline, tetrahydrofuran, 1,3-dioxolane, tetrahydrothiophene, 1,2-oxathiolane, 1,3-oxathiolane, 2,4-thiazolidinedione, succinimide, 2-oxazolidone, hydantoin, γ-butyrolactone, and γ-lactam; piperidine, 6-membered non-aromatic heterocycles such as piperazine, tetrahydropyran, pyran, 1,4-dioxane, thiane, 2H-thiopyran, 4H-thiopyran, 1,3-dithiane, 1,4-dithiane, 1,3,5-trithiane, morpholine, 4H-1,2-oxazine, 6H-1,2-oxazine, 4H-1,3-oxazine, 2H-1,3-oxazine, 6H-1,3-oxazine, thiomorpholine, 2H-1,4-oxazine, δ-valerolactone, and δ-lactam.

[0063] As used herein, "C 1-4The term "hydrocarbyl group" refers to a monovalent group formed by removing one hydrogen atom from a hydrocarbon having 1 to 4 carbon atoms. Hydrocarbyl groups include alkyl groups, alkenyl groups, alkynyl groups, cycloalkyl groups, etc. 1-4 The "hydrocarbyl group" is not particularly limited, and examples thereof include "C 1-4 alkyl group," "C 2-14 alkenyl group," "C 2-4 alkynyl group," "C 3-4 Alicyclic groups" and the like.

[0064] As used herein, "C 1-4 The term "hydrocarbyloxy group" refers to a group consisting of "C 1-4 "C" means a group in which an oxygen atom (-O-) is bonded to a "hydrocarbyl group." 1-4 The "hydrocarbyloxy group" is not particularly limited, and examples thereof include "C" such as a methoxy group, an ethoxy group, an n-propoxy group, an i-propoxy group, an n-butoxy group, an i-butoxy group, a sec-butoxy group, and a t-butoxy group. 1-4 alkoxy group"; cyclopropyloxy group, cyclobutyloxy group, etc. 3-4 Alicyclic oxy group" and the like.

[0065] As used herein, "C 1-4 The term "hydrocarbyl carbonyl group" refers to a group consisting of "C 1-4 It means a group in which a carbonyl group (—C(═O)—) is bonded to a “hydrocarbyl group.” 1-4 The "hydrocarbyl carbonyl group" is not particularly limited, and examples thereof include "C" such as an acetyl group, a propionyl group, an isopropionyl group, a butyryl group, and an isobutyryl group. 1-4 alkylcarbonyl group"; cyclopropylcarbonyl group, cyclobutylcarbonyl group, etc. 3-4 Alicyclic carbonyl groups, etc.

[0066] As used herein, "C 1-4 The term "hydrocarbylcarbonyloxy group" refers to a group consisting of "C 1-4 "C" means a group in which an oxygen atom (-O-) is bonded to a "hydrocarbyl carbonyl group." 1-4The "hydrocarbylcarbonyloxy group" is not particularly limited, and examples thereof include "C" such as a methylcarbonyloxy group, an ethylcarbonyloxy group, an n-propylcarbonyloxy group, an isopropylcarbonyloxy group, an n-butylcarbonyloxy group, an isobutylcarbonyloxy group, and a t-butylcarbonyloxy group. 1-4 alkylcarbonyloxy group"; cyclopropylcarbonyloxy group, cyclobutylcarbonyloxy group, etc. 3-4 Alicyclic carbonyloxy group" and the like.

[0067] As used herein, "C 1-4 The term "hydrocarbyloxycarbonyl group" refers to a group consisting of "C 1-4 It means a group in which a carbonyl group (—C(═O)—) is bonded to a “hydrocarbyloxy group.” 1-4 The "hydrocarbyloxycarbonyl group" is not particularly limited, and examples thereof include "C" such as a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an i-propoxycarbonyl group, an n-butoxycarbonyl group, an i-butoxycarbonyl group, a sec-butoxycarbonyl group, and a t-butoxycarbonyl group. 1-18 alkoxycarbonyl group"; cyclopropyloxycarbonyl group, cyclobutyloxycarbonyl group, etc. 3-18 Alicyclic oxycarbonyl group" and the like.

[0068] As used herein, "C 1-4 The term "hydrocarbylamino group" refers to a group consisting of one "C 1-4 "C" means a group bonded to an amino group. 1-4 The "hydrocarbylamino group" is not particularly limited, and examples thereof include "C" such as methylamino group, ethylamino group, n-propylamino group, i-propylamino group, n-butylamino group, i-butylamino group, sec-butylamino group, and t-butylamino group. 1-4 alkylamino group"; cyclopropylamino group, cyclobutylamino group, etc. 3-4 Alicyclic amino groups, etc.

[0069] As used herein, "diC 1-4The term "hydrocarbylamino group" refers to two identical or different "C 1-4 "DiC" means a group in which a "hydrocarbyl group" is bonded to an amino group. 1-4 The "dihydrocarbylamino group" is not particularly limited, and examples thereof include "diC" such as dimethylamino group, diethylamino group, di-n-propylamino group, diisopropylamino group, di-n-butylamino group, diisobutylamino group, di-t-butylamino group, N-ethyl-N-methylamino group, N-methyl-N-n-propylamino group, N-isopropyl-N-methylamino group, N-n-butyl-N-methylamino group, N-isobutyl-N-methylamino group, and N-t-butyl-N-methylamino group. 1-4 alkylamino group"; dicyclopropylamino group, dicyclobutylamino group, etc. 3-4 Alicyclic amino groups, etc.

[0070] As used herein, "C 1-4 The term "hydrocarbylaminocarbonyl group" refers to a group consisting of "C 1-4 It means a group in which a carbonyl group (—C(═O)—) is bonded to a “hydrocarbylamino group.” 1-4 The "hydrocarbylaminocarbonyl group" is not particularly limited, and examples thereof include "C" such as a methylaminocarbonyl group, an ethylaminocarbonyl group, an n-propylaminocarbonyl group, an i-propylaminocarbonyl group, an n-butylaminocarbonyl group, a sec-butylaminocarbonyl group, and a t-butylaminocarbonyl group. 1-4 alkylaminocarbonyl group"; cyclopropylaminocarbonyl group, cyclobutylaminocarbonyl group, etc. 3-4 Alicyclic aminocarbonyl groups, etc.

[0071] As used herein, "diC 1-4 The term "hydrocarbylaminocarbonyl group" refers to a "diC 1-4 "DiC" means a group in which a carbonyl group (-C(=O)-) is bonded to a "hydrocarbylamino group." 1-4The "hydrocarbylaminocarbonyl group" is not particularly limited, and examples thereof include "diC" groups such as a dimethylaminocarbonyl group, a diethylaminocarbonyl group, a di-n-propylaminocarbonyl group, a diisopropylaminocarbonyl group, a di-n-butylaminocarbonyl group, a diisobutylaminocarbonyl group, a di-t-butylaminocarbonyl group, an N-ethyl-N-methylaminocarbonyl group, an N-methyl-N-n-propylaminocarbonyl group, an N-isopropyl-N-methylaminocarbonyl group, an N-n-butyl-N-methylaminocarbonyl group, an N-isobutyl-N-methylaminocarbonyl group, an N-t-butyl-N-methylaminocarbonyl group, an N-ethyl-N-n-propylaminocarbonyl group, an N-ethyl-N-isopropylaminocarbonyl group, an N-n-butyl-N-ethylaminocarbonyl group, an N-ethyl-N-isobutylaminocarbonyl group, and an N-t-butyl-N-ethylaminocarbonyl group. 1-4 alkylamino group"; "di-C" such as dicyclopropylaminocarbonyl group, dicyclobutylaminocarbonyl group, etc. 3-4 Examples include an alicyclic aminocarbonyl group.

[0072] As used herein, "C 1-4 The term "hydrocarbylcarbonylamino group" refers to a group consisting of "C 1-4 "C" means a group in which an amino group is bonded to a "hydrocarbyl carbonyl group." 1-4 The "hydrocarbylcarbonylamino group" is not particularly limited, and examples thereof include "C" such as methylcarbonylamino group, ethylcarbonylamino group, n-propylcarbonylamino group, i-propylcarbonylamino group, n-butylcarbonylamino group, i-butylcarbonylamino group, sec-butylcarbonylamino group, and t-butylcarbonylamino group. 1-18 alkylcarbonylamino group"; cyclopropylcarbonylamino group, cyclobutylcarbonylamino group, etc. 3-4 Alicyclic carbonylamino group, etc.

[0073] As used herein, "C 1-4 The term "hydrocarbylthio group" refers to a group consisting of "C 1-4"C" means a group in which a sulfur atom (-S-) is bonded to a "hydrocarbyl group." 1-4 The "hydrocarbylthio group" is not particularly limited, and examples thereof include "C" such as a methylthio group, an ethylthio group, an n-propylthio group, an i-propylthio group, an n-butylthio group, an i-butylthio group, and a t-butylthio group. 1-4 alkylthio group"; cyclopropylthio group, cyclobutylthio group, etc. 3-18 Alicyclic thio groups, etc.

[0074] As used herein, "C 1-4 The term "hydrocarbylsulfinyl group" refers to a group consisting of "C 1-4 "C" means a group in which a sulfinyl group (-S(=O)-) is bonded to a "hydrocarbyl group." 1-4 The "hydrocarbylsulfinyl group" is not particularly limited, and examples thereof include "C methylsulfinyl group, ethylsulfinyl group, n-propylsulfinyl group, i-propylsulfinyl group, n-butylsulfinyl group, t-butylsulfinyl group, etc. 1-4 alkylsulfinyl group"; cyclopropylsulfinyl group, cyclobutylsulfinyl group, etc. 3-4 Alicyclic sulfinyl group" and the like.

[0075] As used herein, "C 1-4 The term "hydrocarbylsulfonyl group" refers to a group consisting of "C 1-4 The hydrocarbyl group may be a sulfonyl group (-SO 2 -) is bonded to the group. 1-4 The "hydrocarbylsulfonyl group" is not particularly limited, and examples thereof include "C" such as a methylsulfonyl group, an ethylsulfonyl group, an n-propylsulfonyl group, an i-propylsulfonyl group, an n-butylsulfonyl group, and a t-butylsulfonyl group. 1-4 alkylsulfonyl group"; cyclopropylsulfonyl group, cyclobutylsulfonyl group, etc. 3-4 Alicyclic sulfonyl groups, etc.

[0076] In the present specification, the term "polar substituent" refers to, for example, (1) a hydroxy group, (2) an amino group, (3) a thiol group, (4) an aldehyde group, (5) a carboxy group, (6) a cyano group, (7) a nitro group, (8) an amide group, (9) a sulfo group, or (10) a group in which at least a portion of the hydrogen atoms is substituted with (1) to (9), or a divalent carbon atom at any position excluding the terminal is substituted with -O-, -C(=O)-, -C(=O)O-, -OCO-, CONH, -NHCO-, -S-, or -SO 2 C substituted with - 1-4 a hydrocarbyl group, or (11) a C in which at least a portion of the hydrogen atoms may be substituted with (1) to (9) 1-4 Hydrocarbyloxy group, C 1-4 Hydrocarbyl carbonyl group, C 1-4 Hydrocarbylcarbonyloxy group, C 1-4 Hydrocarbyloxycarbonyl group, C 1-4 Hydrocarbyloxycarbonyloxy group, C 1-4 Hydrocarbylamino group, diC 1-4 Hydrocarbylamino group, C 1-4 Hydrocarbylaminocarbonyl group, diC 1-4 Hydrocarbylaminocarbonyl group, C 1-4 Hydrocarbylcarbonylamino group, C 1-4 Hydrocarbylthio group, C 1-4 Hydrocarbylsulfinyl group, C 1-4 Examples thereof include a hydrocarbylsulfonyl group.

[0077] As used herein, the term "hydroxy group or carboxy group having a protecting group" refers to a hydroxy group (including a phenolic hydroxy group) or a carboxy group that is protected with an ether-based protecting group, a silyl ether-based protecting group, an acyl-based protecting group, an aminocarbonyl-based protecting group, or the like.

[0078] The ether-based protecting group is not particularly limited, and examples thereof include a methyl group, a benzyl group, a p-methoxybenzyl group, a t-butyl group, a triphenylmethyl group, a p-methoxyphenyldiphenylmethyl group, and a di(p-methoxyphenyl)phenylmethyl group. The silyl ether-based protecting group is not particularly limited, and examples thereof include a t-butyldimethylsilyl group (TBS), a triisopropylsilyl group (TIPS), a trimethylsilyl group (TMS), a triethylsilyl group (TES), and a t-butyldiphenylsilyl group (TBDPS). The acyl-based protecting group is not particularly limited, and examples thereof include an acetyl group, a pivaloyl group, and a benzoyl group. The aminocarbonyl-based protecting group is not particularly limited, and examples thereof include a dimethylaminocarbonyl group, a diethylaminocarbonyl group, a diisopropylaminocarbonyl group, and an N-phenyl-N-methyl-aminocarbonyl group.

[0079] <First Solvent> The treatment liquid according to this embodiment is characterized by containing 20% ​​by mass or more of a first solvent, which is at least one solvent selected from the group consisting of the following (1) to (4): The treatment liquid more preferably contains 20 to 80% by mass of the first solvent, and even more preferably contains 20 to 50% by mass of the first solvent. (1) A benzene ring in which one or more hydrogen atoms are substituted with a polar substituent. (2) A 5- or 6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent. (3) A 5- or 6-membered hydrocarbon ring having one or more double bonds in the ring and at least one or more hydrogen atoms substituted with a polar substituent, or having a carbonyl group in the ring and at least one or more hydrogen atoms may be substituted with a polar substituent. (4) A 5- or 6-membered non-aromatic heterocycle in which at least one or more hydrogen atoms are substituted with a polar substituent, or having a total of two or more heteroatoms and carbonyl groups in the ring and at least one or more hydrogen atoms may be substituted with a polar substituent. These solvents (1) to (4) may be used alone or in combination of two or more.

[0080] (Benzene ring in which one or more hydrogen atoms are substituted with polar substituents) The "benzene ring in which one or more hydrogen atoms are substituted with polar substituents" used in the treatment liquid according to this embodiment is not particularly limited, and a known or commonly used one can be used. Note that, in the benzene ring, it is sufficient that one or more hydrogen atoms are substituted with polar substituents, and the remaining hydrogen atoms are C 1-4 It may be substituted with a hydrocarbyl group.

[0081] Examples of the "benzene ring in which one or more hydrogen atoms are substituted with a polar substituent" include phenol, anisole, 2-phenoxyethanol, o-cresol, m-cresol, p-cresol, 2-aminophenol, 3-aminophenol, 4-aminophenol, catechol, benzoic acid, methyl benzoate, ethyl benzoate, methyl 2-methoxybenzoate, methyl 3-methoxybenzoate, methyl 4-methoxybenzoate, aniline, N-methylaniline, N-ethylaniline, N,N-dimethylaniline, 2-methoxyaniline, phosphorus, 3-methoxyaniline, 4-methoxyaniline, butylphenyl ether, 4-methylsalicylic acid, trans-o-coumaric acid, trans-m-coumaric acid, trans-p-coumaric acid, 1,2-dimethoxybenzene, 1,3-dimethoxybenzene, 1,4-dimethoxybenzene, 2,6-dimethylphenol, 3,4-dimethoxytoluene, 2-ethoxyphenol, 2-hydroxybenzoic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, methyl 2-hydroxybenzoate, methyl 3-hydroxybenzoate, 4 -Methyl hydroxybenzoate, o-vanillin, 4-hydroxyphenylacetic acid, 4-(4-hydroxyphenyl)-2-butanone, 4-hydroxybenzyl cyanide, 3-hydroxybenzyl alcohol, 4-methoxyacetophenone, 4-methoxyphenol, O-methyl-m-coumaric acid, thymol, benzaldehyde, acetophenone, propiophenone, o-tolualdehyde, m-tolualdehyde, p-tolualdehyde, benzamide, salicylaldehyde, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoin Acid, 4-methoxybenzaldehyde, anthranilic acid, butyrophenone, 2-formylbenzonitrile, isobutylphenyl ketone, mandelic acid, dimethyl phthalate, dimethyl terephthalate, diethyl terephthalate, ethyl p-toluate, gallic acid, benzonitrile, 2-cyanotoluene, 3-cyanotoluene, 4-cyanotoluene, 2-aminobenzonitrile, 3-aminobenzonitrile, 4-aminobenzonitrile, 2-hydroxybenzonitrile, 3-hydroxybenzonitrile, 4-hydroxybenzonitrile, 2,Examples of such compounds include 4-dimethoxybenzonitrile, nitrobenzene, 3-nitrobenzonitrile, phthalonitrile, benzyl alcohol, 1,4-bis(methoxymethyl)benzene, 1,4-benzenedimethanol, 4-methylbenzyl alcohol, benzylamine, 1-phenylethylamine, 4-methylbenzylamine, N-methylbenzylamine, benzyl acetate, o-toluidine, benzenethiol, thioanisole, o-toluenethiol, m-toluenethiol, p-toluenethiol, 2-aminobenzenethiol, 3-aminobenzenethiol, 2-hydroxybenzenethiol, 3-hydroxybenzenethiol, 4-hydroxybenzenethiol, benzyl mercaptan, 4-methylbenzyl mercaptan, 4-methoxybenzyl mercaptan, 2-(benzylthio)ethanol, and benzyl methyl sulfide.

[0082] As the solvent used in the treatment liquid according to this embodiment, from the viewpoint that the molecule is partially planar and has asymmetry due to a polar substituent, among these solvents, nitrobenzene, benzonitrile, phenol, aniline, anisole, dimethoxybenzene, N-methylaniline, N-ethylaniline, thioanisole, ethyl phenyl sulfide, benzaldehyde, acetophenone, propiophenone, 2-phenoxyethanol, 2-(benzylthio)ethanol, methyl benzoate, ethyl benzoate, benzyl alcohol, benzylamine, 1-phenylethylamine, and benzyl mercaptan are preferred, and nitrobenzene, benzonitrile, phenol, aniline, anisole, thioanisole, benzaldehyde, acetophenone, 2-phenoxyethanol, benzyl alcohol, and benzylamine are more preferred.

[0083] (5- or 6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent) The "5- or 6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent" used in the treatment liquid according to this embodiment is not particularly limited, and a known or commonly used one can be used. Note that in the 5- or 6-membered aromatic heterocycle, one or more hydrogen atoms may be substituted with a polar substituent, or one or more hydrogen atoms may be C1-4 It may be substituted with a hydrocarbyl group.

[0084] Examples of the "5-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent" include pyrrole, 3-methylpyrrole, 1-methylpyrrole, 1-ethylpyrrole, 1-aminopyrrole, 1H-pyrrole-2-carbonitrile, pyrrole-2-carbaldehyde, pyrrole-3-carbaldehyde, 2,5-dimethylpyrrole, 2-ethylpyrrole, 2,4-dimethylpyrrole, 1-methylpyrrole-2-carbonitrile, 2-acetylpyrrole, 2-acetyl-1-methylpyrrole, Examples include 2-acetyl-1-ethylpyrrole, furan, 2-methylfuran, 2-furonitrile, furfural, 3-furaldehyde, furfurylamine, furfuryl alcohol, 3-furanmethanol, 2-acetylfuran, 2-acetyl-5-methylfuran, 3-acetyl-2,5-dimethylfuran, 5-acetoxymethylfurfural, dimethyl furan-2,5-dicarboxylate, furfuryl mercaptan, 2-furancarboxylic acid, ethyl 2-furancarboxylate, and furfuryl methyl sulfide.

[0085] Examples of the "6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent" include pyridine, 2-pyridinemethanol, 3-pyridinemethanol, 2-(1-hydroxyethyl)pyridine, 2-methoxypyridine, 2-ethoxypyridine, 3-methoxypyridine, 3-ethoxypyridine, 2-methylpyridine, 3-methylpyridine, 4-methylpyridine, 2-aminopyridine, 3-aminopyridine, 4-aminopyridine, 3-hydroxypyridine, 4-hydroxypyridine, 2-acetylpyridine, 3-acetylpyridine, 4-acetylpyridine, 2-cyanopyridine, 2-cyano-4-nitropyridine, 3,4-diaminopyridine, 4-dimethylaminopyridine, isonicotinamide, methyl pyridine-4-carboxylate, pyridine-4-carboxylic acid, nicotinamide, methyl 4-pyridine, methyl 4-pyridine, methyl 4-pyridine, methyl 5-pyridine, methyl 6-pyridine, methyl 7-pyridine, methyl 8-pyridine, methyl 9-pyridine, methyl 10-pyridine, methyl 11-pyridine, methyl 12-pyridine, methyl 13-pyridine, methyl 14-pyridine, methyl 15-pyridine, methyl 16-pyridine, methyl 17-pyridine, methyl 18-pyridine, methyl 19-pyridine, methyl 20-pyridine, methyl 21-pyridine, methyl 22-pyridine, methyl 23-pyridine, methyl 24-pyridine, methyl 25-pyridine, methyl 26-pyridine, methyl 27-pyridine, methyl amide, nicotinic acid, 2-aminonicotinic acid, 6-aminonicotinic acid, pyridine-2-carboxylic acid, 3-pyridylacetic acid, 2,3-dihydroxypyridine, 2-(aminomethyl)pyridine, 3-(aminomethyl)pyridine, 3-(2-aminoethyl)pyridine, 2-amino-3-methylpyridine, 2-amino-4-methylpyridine, 2-amino-5-methylpyridine, 2-amino-6-methylpyridine, 2-amino-5-cyanopyridine, 4-acetamidopyridine, 2-acetamidopyridine, 2-aminopyrimidine, 5-aminopyrimidine, 2-cyanopyrimidine, 4-hydroxy-6-methylpyrimidine, 3-methoxypyrimidine, 4-methoxypyrimidine, pyridazine-4-carboxylic acid, 1,3,5-triazine, and 2,4-diamino-1,3,5-triazine.

[0086] As the solvent used in the treatment liquid according to the present embodiment, from the viewpoint that the molecule is partially planar and has polarity, among these solvents, 1-aminopyrrole, 1H-pyrrole-2-carbonitrile, pyrrole-2-carbaldehyde, pyrrole-3-carbaldehyde, 2-acetylpyrrole, 2-furonitrile, furfural, 3-furaldehyde, furfurylamine, furfuryl alcohol, 3-furanmethanol, 2-acetylfuran, 5-acetoxymethylfurfural, furfuryl mercaptan, 2-furancarboxylic acid, 2-furanmethanol, 2-acetylfuran, 5-acetoxymethylfurfural, furfuryl mercaptan, 2-furancarboxylic acid, 2-furanmethanol, 2-furanmethanol, 2-acetylfuran, 2-furanmethanol ... methyl 2-furancarboxylate, ethyl 2-furancarboxylate, furfuryl methyl sulfide, pyridine, 2-pyridinemethanol, 3-pyridinemethanol, 2-(1-hydroxyethyl)pyridine, 2-methoxypyridine, 2-ethoxypyridine, 3-methoxypyridine, 3-ethoxypyridine, 2-aminopyridine, 3-aminopyridine, 4-aminopyridine, 3-hydroxypyridine, 4-hydroxypyridine, 2-acetylpyridine, 3-acetylpyridine, 4-acetylpyridine, 2-cyanopyridine, 2-cyano-4-nitropyridine, 3,Preferred are 4-diaminopyridine, 4-dimethylaminopyridine, isonicotinamide, methyl pyridine-4-carboxylate, pyridine-4-carboxylic acid, nicotinamide, nicotinic acid, 2-aminonicotinic acid, 6-aminonicotinic acid, pyridine-2-carboxylic acid, 3-pyridylacetic acid, 2-(aminomethyl)pyridine, 3-(aminomethyl)pyridine, 3-(2-aminoethyl)pyridine, 4-acetamidopyridine, 2-acetamidopyridine, 2-aminopyrimidine, 5-aminopyrimidine, 2-cyanopyrimidine, 3-methoxypyrimidine, 4-methoxypyrimidine, and pyridazine-4-carboxylic acid. 2-furonitrile, furfural, 3-furaldehyde, furfurylamine, furfuryl alcohol, 3-furanmethanol, 2-acetylfuran, methyl 2-furancarboxylate, furfuryl methyl sulfide, pyridine, 2-pyridinemethanol, 3-pyridinemethanol, 2-(1-hydroxyethyl)pyridine, 2-methoxypyrimidine, More preferred are lysine, 2-ethoxypyridine, 3-methoxypyridine, 3-ethoxypyridine, 2-(aminomethyl)pyridine, 3-(aminomethyl)pyridine, 3-(2-aminoethyl)pyridine, 2-aminopyridine, 3-aminopyridine, 4-aminopyridine, 3-hydroxypyridine, 4-hydroxypyridine, 2-acetylpyridine, 3-acetylpyridine, 4-acetylpyridine, and 2-cyanopyridine, and even more preferred are furfural, 3-furaldehyde, furfurylamine, furfuryl alcohol, 3-furanmethanol, 2-pyridinemethanol, 3-pyridinemethanol, 2-(1-hydroxyethyl)pyridine, 2-methoxypyridine, 2-ethoxypyridine, 3-methoxypyridine, 3-ethoxypyridine, 2-(aminomethyl)pyridine, 3-(aminomethyl)pyridine, and 3-(2-aminoethyl)pyridine, which are 5- or 6-membered aromatic heterocycles in which one or more hydrogen atoms are substituted with polar substituents.

[0087] (Five- or six-membered hydrocarbon ring having one or more double bonds in the ring and at least one or more hydrogen atoms substituted with a polar substituent, or having a carbonyl group in the ring and at least one or more hydrogen atoms optionally substituted with a polar substituent) The "five- or six-membered hydrocarbon ring having one or more double bonds in the ring and at least one or more hydrogen atoms optionally substituted with a polar substituent, or having a carbonyl group in the ring and at least one or more hydrogen atoms optionally substituted with a polar substituent" used in the treatment liquid according to this embodiment is not particularly limited, and any known or commonly used one can be used. Note that in the five- or six-membered hydrocarbon ring, when one or more hydrogen atoms are C 1-4 It may be substituted with a hydrocarbyl group.

[0088] Examples of "a five- or six-membered hydrocarbon ring having one or more double bonds in the ring and at least one or more hydrogen atoms substituted with a polar substituent" include 1-cyclopentenecarboxylic acid, 1-acetyl-1-cyclopentene, 1-methoxycyclopentene, 3-cyclopentene-1-methanol, 3-methoxy-2-cyclopenten-1-one, 1-acetyl-1-cyclopenten-3-one, 1-cyclohexen-1-ol, 3-methoxycyclohexene, 3 1-cyclohexene-1-methanol, 1-cyclohexene-1-carboxylic acid, 3-cyclohexene-1-carboxylic acid, 4-methyl-3-cyclohexene-1-carboxylic acid, methyl 3-cyclohexene-1-carboxylate, cis-4-cyclohexene-1,2-dicarboxylic acid, 3-cyclohexene-1-carboxaldehyde, 1-acetyl-1-cyclohexene, 4-acetyl-1-cyclohexene, 2-amino-2-cyclohexen-1-one, and the like.

[0089] Examples of the "5- or 6-membered hydrocarbon ring having a carbonyl group within the ring and at least one of the hydrogen atoms optionally substituted with a polar substituent" include cyclopentanone, cyclohexanone, 2-cyclopenten-1-one, 1,3-cyclopentanedione, 3-hydroxy-3-methyl-2-cyclopentenone, 2-acetylcyclopentanone, ethyl 2-oxocyclopentanecarboxylate, 2-cyclohexen-1-one, 3-methyl-2-cyclohexen-1-one, 3-aminocyclohexanone, 2-methoxycyclohexanone, and 4-acetamidocyclohexanone.

[0090] As the solvent used in the treatment liquid according to this embodiment, from the viewpoint of having a double bond or a carbonyl group that induces planarity in a part of the molecule and having polarity, among these solvents, 1-acetyl-1-cyclopentene, 3-cyclopentene-1-methanol, 1-cyclohexen-1-ol, 3-methoxycyclohexene, 3-cyclohexene-1-methanol, methyl 3-cyclohexene-1-carboxylate, 1-acetyl-1-cyclohexene, 4-acetyl-1-cyclohexene, cyclopentanone, 2-cyclohexen-1-one, cyclohexanone, 2-acetylcyclopentanone, 2-methoxycyclohexanone, 4-acetyl-1-cyclohexene, cyclopentanone, cyclohex ... -acetamidocyclohexanone is preferred, 1-acetyl-1-cyclopentene, 1-cyclohexen-1-ol, 3-methoxycyclohexene, methyl 3-cyclohexene-1-carboxylate, 1-acetyl-1-cyclohexene, 4-acetyl-1-cyclohexene, 2-cyclohexen-1-one, cyclopentanone, cyclohexanone, 2-acetylcyclopentanone is more preferred, and 1-acetyl-1-cyclohexene, 4-acetyl-1-cyclohexene, 2-cyclohexen-1-one, cyclopentanone, cyclohexanone, 2-acetylcyclopentanone is even more preferred.

[0091] (A 5- or 6-membered non-aromatic heterocycle in which at least one hydrogen atom is substituted with a polar substituent, or which has two or more heteroatoms or carbonyl groups in total in the ring, and at least one hydrogen atom may be substituted with a polar substituent) The "5- or 6-membered non-aromatic heterocycle in which at least one hydrogen atom is substituted with a polar substituent, or which has two or more heteroatoms or carbonyl groups in total in the ring, and at least one hydrogen atom may be substituted with a polar substituent" used in the treatment liquid according to this embodiment is not particularly limited, and known or commonly used ones can be used. Note that in the above 5- or 6-membered non-aromatic heterocycle, when one or more hydrogen atoms are C 1-4 It may be substituted with a hydrocarbyl group.

[0092] Examples of the "5- or 6-membered non-aromatic heterocycle in which at least one hydrogen atom is substituted with a polar substituent" include 3-aminopyrrolidine, 3-pyrrolidinol, 2-(methoxymethyl)pyrrolidine, prolinol, proline, 2,5-dimethoxytetrahydrofuran, 1,4-anhydroerythritol, 2-aminomethyl-1-methylpyrrolidine, 2-aminomethyl-2-ethylpyrrolidine, tetrahydro-2H-pyran-4-amine, tetrahydro-4-pyranol, 4-aminomethyltetrahydropyran, penta-O-acetyl-β-D- Glucopyranose, galactose, 4-aminopiperidine, 2-piperidinemethanol, 3-piperidinemethanol, 1-methyl-3-piperidinemethanol, 3-piperidinecarboxylic acid, ethyl 2-piperidinecarboxylate, ethyl 3-piperidinecarboxylate, 3-(aminomethyl)piperidine, 4-(aminomethyl)piperidine, 3-hydroxypiperidine, 4-hydroxypiperidine, 4-acetamidopiperidine, 4-amino-1-methylpiperidine, 1-acetyl-4-piperidinecarboxylic acid, and 2-amino-1-pyrroline.

[0093] Examples of "a 5- or 6-membered non-aromatic heterocycle having two or more heteroatoms or carbonyl groups in total within the ring, and at least one or more hydrogen atoms of which may be substituted with a polar substituent" include tetrahydro-4H-pyran-4-one, δ-valerolactone, glutaric anhydride, δ-hexanolactone, 1,4-dioxane, 1,4-dioxane 2,3-diol, 2-pyrrolidone, 5-methyl-2-pyrrolidone, 1-methyl-2-pyrrolidone, 2-piperidone, 1-acetyl 4-piperidone, γ-butyrolactone, γ-crotonolactone, maleic anhydride, maleimide, N-methylmaleimide, N-(2-hydroxyethyl)maleimide, α-angelicalactone, 4-methyl-2(5H)-furanone, 3-methyl-2(5H)-furanone, 2-methyltetrahydrofuran-3-one, α-hydroxy-γ-butyrolactone, α-amino-γ-butyrolactone, araboascorbic acid, erythronolactone, 1-methyl-2-pyridone, and the like.

[0094] As the solvent used in the treatment liquid according to this embodiment, from the viewpoint of inducing planarity by having polarity or having a carbonyl group in the ring, among these solvents, 2-(methoxymethyl)pyrrolidine, prolinol, 2-aminomethyl-1-methylpyrrolidine, tetrahydro-2H-pyran-4-amine, tetrahydro-4-pyranol, 4-aminomethyltetrahydropyran, 2-piperidinemethanol, 3-piperidinemethanol, 3-(aminomethyl)piperidine, 4-(aminomethyl)piperidine, 3-hydroxypiperidine, 4-hydroxypiperidine, 4-acetamidopiperidine, δ-valerolactone, glutaric anhydride, δ-hexanolactone, 2-pyrrolidone, 5-methylpropanol ... Preferred are 1-methyl-2-pyrrolidone, 1-methyl-2-pyrrolidone, 2-piperidone, γ-butyrolactone, γ-crotonolactone, maleic anhydride, and maleimide, and more preferred are 2-(methoxymethyl)pyrrolidine, prolinol, 2-aminomethyl-1-methylpyrrolidine, 4-aminomethyltetrahydropyran, 2-piperidinemethanol, 3-piperidinemethanol, 3-(aminomethyl)piperidine, 4-(aminomethyl)piperidine, δ-valerolactone having one or more heteroatoms and one or more carbonyl groups in the ring, glutaric anhydride, δ-hexanolactone, 2-pyrrolidone, 2-piperidone, γ-butyrolactone, γ-crotonolactone, maleic anhydride, and maleimide.

[0095] <Second Solvent> The treatment liquid according to this embodiment may contain 1 to 80 mass % of one or more second solvents different from the first solvent.

[0096] Examples of the second solvent that can be used include water, alcohol solvents, amide solvents, ester solvents, ether solvents, ketone solvents, and hydrocarbon solvents. Examples of alcohol solvents include MeOH, EtOH, n-propyl alcohol, i-propyl alcohol, n-butyl alcohol, sec-butyl alcohol, tert-butyl alcohol, isobutyl alcohol, n-hexyl alcohol, and n-heptyl alcohol; glycols such as ethylene glycol, diethylene glycol, and triethylene glycol; and glycol ethers having a hydroxyl group such as ethylene glycol monomethyl ether, propylene glycol monomethyl ether, diethylene glycol monomethyl ether, triethylene glycol monoethyl ether, methoxymethylbutanol, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, and propylene glycol monobutyl ether. Examples of amide solvents include dimethylformamide, dimethylacetamide, and N-methyl-2-pyrrolidone. Examples of ester solvents include methyl acetate, butyl acetate, ethyl acetate, isopropyl acetate, amyl acetate, isoamyl acetate, ethyl methoxyacetate, ethyl ethoxyacetate, methyl 2-hydroxyisobutyrate, ethyl lactate, butyl lactate, propyl lactate, ethyl carbonate, propyl carbonate, butyl carbonate, propylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol monopropyl ether acetate, ethylene glycol monobutyl ether acetate, diethylene glycol monomethyl ether acetate, diethylene glycol monopropyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol monoethyl ether acetate, 2-methoxybutyl acetate, 3-methoxybutyl acetate, and 4-methoxybutyl acetate.Examples of ether solvents include propylene glycol dimethyl ether, propylene glycol diethyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, 1,4-dioxane, tetrahydrofuran, and anisole. Examples of ketone solvents include acetone, 1-heptanone, 1-hexanone, 2-hexanone, diisobutyl ketone, cycloheptanone, cyclohexanone, methyl ethyl ketone, acetylacetone, and γ-butyrolactone. Examples of hydrocarbon solvents include aliphatic hydrocarbon solvents such as n-pentane, iso-pentane, n-hexane, iso-hexane, n-heptane, iso-heptane, 2,2,4-trimethylpentane, n-octane, iso-octane, cyclohexane, and methylcyclohexane; and aromatic hydrocarbon solvents such as benzene, toluene, xylene, mesitylene, ethylbenzene, trimethylbenzene, and methylethylbenzene. These solvents may be used alone or in combination of two or more.

[0097] The second solvent is preferably one or more solvents selected from the group consisting of ketone-based solvents, ester-based solvents, alcohol-based solvents, amide-based solvents, ether-based solvents, hydrocarbon-based solvents, and water.

[0098] <Use of Treatment Solution> The treatment solution can be suitably used as a developer for developing the metal compound-containing film after the exposure step, and as a rinse solution for rinsing the developed metal compound-containing film. In particular, the treatment solution according to this embodiment has a difference in solubility between the exposed and unexposed parts of the metal compound-containing film, and can create a contrast between the exposed and unexposed parts. For this reason, the metal compound-containing film can be treated with an ArF excimer laser (wavelength 193 nm), a KrF excimer laser (248 nm), or an F 2The treatment solution can be suitably used as a negative developer for developing a metal compound-containing film after exposure to an excimer laser (wavelength 157 nm), EUV (extreme ultraviolet), VUV (vacuum ultraviolet), EB (electron beam), X-ray, etc. In other words, the unexposed portions of the metal compound-containing film can be selectively dissolved and removed by the treatment solution to form a metal compound-containing film pattern.

[0099] [1-4-2. Treating Step] The pattern forming method according to this embodiment includes a step of treating the exposed metal compound-containing film with a treating liquid.

[0100] The method of developing the metal compound-containing film using the treatment liquid as the developer is not particularly limited, and can use known and commonly used methods.As the method of developing using the treatment liquid, for example, the method of immersing the substrate with the metal compound-containing film after exposure in the treatment liquid for a certain time (dipping method), the method of spraying the treatment liquid on the surface of the metal compound-containing film after exposure (spray method), the method of ejecting the treatment liquid from an ejection nozzle at a certain speed toward the surface of the metal compound-containing film after exposure on the substrate that rotates at a certain speed (dynamic dispensing method) etc.

[0101] In addition, the method for cleaning the developed metal compound-containing film pattern using the treatment liquid as a rinsing liquid is not particularly limited, and any known or commonly used method can be used. Examples of the method for rinsing using the treatment liquid include a method of immersing a substrate having a metal compound-containing film pattern in the treatment liquid for a certain period of time (dipping method), a method of spraying the treatment liquid onto the surface of the metal compound-containing film pattern (spray method), and a method of ejecting the treatment liquid from an ejection nozzle at a constant speed toward the surface of the metal compound-containing film pattern on a substrate rotating at a constant speed (spin coating method).

[0102] [2. Metal Compound-Containing Film Treatment Solution] The metal compound-containing film treatment solution according to this embodiment is characterized by containing 20% ​​by mass or more of a first solvent, which is one or more selected from the group consisting of: (1) a benzene ring in which one or more hydrogen atoms are substituted with a polar substituent; (2) a five- or six-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent; (3) a five- or six-membered hydrocarbon ring having one or more double bonds in the ring and at least one hydrogen atom being substituted with a polar substituent, or having a carbonyl group in the ring and at least one hydrogen atom being substituted with a polar substituent; and (4) a five- or six-membered non-aromatic heterocycle in which at least one hydrogen atom is substituted with a polar substituent, or having a total of two or more heteroatoms or carbonyl groups in the ring and at least one hydrogen atom being substituted with a polar substituent.

[0103] The metal compound-containing film treatment solution according to another embodiment may further contain 1 to 80 mass % or more of one or more second solvents different from the first solvent in the treatment solution. The second solvent is preferably one or more solvents selected from the group consisting of ketone-based solvents, ester-based solvents, alcohol-based solvents, amide-based solvents, ether-based solvents, hydrocarbon-based solvents, and water, which are different from the first solvent.

[0104] The metal compound-containing film treatment solution according to this embodiment is capable of forming a good pattern even when the metal compound-containing film contains a polyoxometalate as the metal compound, and can be suitably used as a polyoxometalate-containing film treatment solution.

[0105] EXAMPLES The present invention will be specifically explained below by showing examples, but the present invention is not limited to these examples.

[0106] [1. Preparation of Test Metal Compound-Containing Film-Forming Composition F] Hexakis(bis(2-trifluoromethylphenyl)phenylsulfonium)metatungstate (metal compound M) as a metal compound, and dimethylformamide (DMF) and ethyl lactate (EL) as solvents were blended so that the contents of each component were in the amounts (unit: parts by mass) shown in Table 1, and the mixture was mixed with a stirrer to prepare a test metal compound-containing film-forming composition F.

[0107]

[0108] <Synthesis of Metal Compound M> Metal compound M was synthesized by the following method and used to prepare a test metal compound-containing film-forming composition F. 6.68 g of bis(2-trifluoromethylphenyl)phenylsulfonium chloride was dissolved in 99.36 g of pure water to obtain ammonium metatungstate (ammonium metatungstate hydrate ((NH 4 ) 6 [H 2 W 12 O 40 ]・xH 2 6.88 g of methyl methyl ketone (MgO) was added, and the reaction solution was stirred at room temperature for 30 minutes. The reaction solution was filtered, and the resulting powder was dried under reduced pressure at room temperature for 18 hours. The dried powder was dissolved in 100 g of dimethylformamide, and then 335 g of methanol was added. Crystallization at room temperature yielded metal compound M.

[0109] [2. Preparation of Test Film] <Film Formation Step> Test metal compound-containing film-forming composition F was applied using a spinner onto an 8-inch silicon substrate that had been treated with hexamethyldisilazane (HDMS), and the substrate was subjected to a post-applied bake (PAB) treatment on a hot plate at a temperature of 200°C for 60 seconds, followed by drying, to form a test metal compound-containing film with a film thickness of 50 nm. The average thickness of the formed metal compound-containing film was measured using a film thickness measuring device ("M-2000D" manufactured by J.A. Woollam Co.).

[0110] <Exposure Step> The test metal compound-containing film was exposed to light by open frame exposure using a KrF exposure device ("NSR-S203B" manufactured by NIKON Corporation, NA (numerical aperture) = 0.68, σ = 0.75) at an exposure dose of 50 mJ / cm2 After the exposure, a post-exposure bake (PEB) treatment was carried out at 180° C. for 60 seconds to prepare a test film.

[0111] [3. Investigation and Evaluation of Treatment Solutions (Single Solvent)] The test films were developed for 60 seconds at 23° C. using treatment solutions A-1 to A-9 (benzene ring or aromatic heterocycle) and B-1 to B-10 (non-aromatic heterocycle, aromatic heterocycle, or hydrocarbon ring) shown in Tables 2 and 3 below, and then rinsed for 15 seconds at 23° C. using 2-propanol. Thereafter, the change in film thickness between the exposed and unexposed areas was measured using a film thickness measuring device.

[0112] <Film reduction in unexposed areas> Focusing on the change in film thickness before and after development in the unexposed areas of the test film, the film reduction in unexposed areas (= ((film thickness before development - film thickness after development) / film thickness before development) x 100 (%)) was calculated, and the developability of each processing liquid was evaluated according to the following criteria. The results are shown in Table 2. A (very good): Film reduction in unexposed areas was 80% or more and 100% or less B (good): Film reduction in unexposed areas was 40% or more and less than 80% C (poor): Film reduction in unexposed areas was less than 40%

[0113]

[0114] From Table 2, it can be seen that when a solvent having a hydroxyl group substituted by a hydrogen atom on the benzene ring or aromatic heterocycle is used as a treatment solution, as in treatment solutions A-1, A-2, A-7, and A-8, the evaluation of the film loss in the unexposed portion of the test film is all rated as A, giving good results. Similarly, when a solvent having a polar substituent such as a nitro group, an amino group, a methoxy group, or an acetyl group substituted by a hydrogen atom on the benzene ring is used as a treatment solution, as in treatment solutions A-3, A-4, A-5, and A-6, the evaluation of the film loss in the unexposed portion of the test film is all rated as A, giving good results. On the other hand, when toluene is used as a solvent, as in treatment solution A-9, the evaluation of the film loss in the unexposed portion is C.

[0115]

[0116] From Table 3, it can be seen that when a solvent in which the hydrogen atom of the non-aromatic heterocycle is substituted with a polar substituent having a hydroxyl group, or a solvent having a carbonyl group and a heteroatom in the ring of the non-aromatic heterocycle, such as treatment solutions B-1 and B-2, is used as a treatment solution, the evaluation of the film loss in the unexposed portion of the test film is all judged as A, and good results are obtained.Furthermore, when a solvent in which the hydrogen atom of the aromatic heterocycle is substituted with a polar substituent having a hydroxyl group or an aldehyde group, such as treatment solutions B-3 and B-4, is used as a treatment solution, the evaluation of the film loss in the unexposed portion of the test film is all judged as A, and good results are obtained. Furthermore, as in processing solutions B-5 to B-7, the planarity of the cyclic compound is improved by having a double bond or a carbonyl group in the hydrocarbon ring, and when a double bond is present in the hydrocarbon ring, when a solvent having a polar substituent such as an aldehyde group is used as the processing solution, as in processing solution B-7, the evaluation of the film loss in the unexposed portion of the test film is all rated as A, indicating that good results are obtained. On the other hand, when a solvent having no polar substituent in the non-aromatic heterocycle and no carbonyl group or heteroatom in the ring is used as the processing solution, as in processing solutions B-8 and B-9, the evaluation of the film loss in the unexposed portion is C. Furthermore, when a solvent having no double bond or carbonyl group in the hydrocarbon ring, even if the hydrogen atom of the hydrocarbon group is substituted with a hydroxy group, is used as the processing solution, as in processing solution B-10, the evaluation of the film loss in the unexposed portion is C.

[0117] [4. Investigation and Evaluation of Treatment Solutions (Mixed Solvents with PGMEA)] The test films were developed for 60 seconds using treatment solutions C-1 to C-7 (combinations of benzyl alcohol and PGMEA) listed in Table 4 below, treatment solutions D-1 to D-7 (combinations of anisole and PGMEA) listed in Table 5 below, and treatment solutions E-1 to E-7 (combinations of acetophenone and PGMEA) listed in Table 6 below, and then rinsed for 15 seconds with 2-propanol. The change in film thickness between the exposed and unexposed areas was then measured using a film thickness measurement device. Tables 4 to 6 show the (mass) ratios of solvents 1 and 2 in each treatment solution.

[0118] <Film reduction amount in unexposed portion> Focusing on the change in film thickness before and after development in the unexposed portion of the test film, the film reduction amount in the unexposed portion (= (film thickness before development - film thickness after development) / film thickness before development) × 100 (%)) was calculated, and the developability of each processing liquid was evaluated according to the same criteria as above. The results are shown in Tables 4 to 6.

[0119] <Evaluation of Selectivity> Focusing on the change in film thickness after development between the unexposed and exposed parts of the test film, the selectivity ratio (= film reduction amount in unexposed part / film reduction amount in exposed part) was calculated, and the selectivity of each treatment solution was evaluated according to the following criteria. The results are shown in Tables 4 to 6. A (Very good): Selectivity ratio of 20 or more B (Good): Selectivity ratio of 10 or more but less than 20 C (Bad): Selectivity ratio less than 10

[0120]

[0121]

[0122]

[0123] From Table 4, it can be seen that when the treatment solution contains 20% by mass or more of benzyl alcohol in which the hydrogen atoms of the benzene ring are substituted with polar substituents having a hydroxy group, as in treatment solutions C-1 to C-4, good results are obtained in both the evaluation of the unexposed film loss and the selectivity of the test membrane. Interestingly, from the results of the selectivity ratios of treatment solutions C-1 and C-2 and treatment solutions C-3 and C-4 in Table 4, it can be seen that by adding 50 to 80% by mass of PGMEA in addition to benzyl alcohol, it is possible to more selectively reduce the film in the unexposed portion compared to the exposed portion of the test membrane. On the other hand, as in treatment solutions C-5 to C-7, when the content of benzyl alcohol in the treatment solution is 10% by mass or less, the lower the content of benzyl alcohol, the worse the results of the unexposed film loss and the selectivity of the test membrane tended to be.

[0124] Furthermore, from Table 5, it can be seen that when the treatment solution contains 20% by mass or more of anisole as the first solvent, as in treatment solutions D-1 to D-4, good results are obtained in both the evaluation of the unexposed film loss and the selectivity of the test membrane. Furthermore, from the results of treatment solutions D-1 to D-4, in the case of anisole, a lower content of PGMEA tends to give better results in both the evaluation of the unexposed film loss and the selectivity of the test membrane. On the other hand, as in treatment solutions D-5 to D-7, when the content of anisole in the treatment solution is 10% by mass or less, the lower the anisole content, the worse the results of the unexposed film loss and the selectivity of the test membrane tend to be.

[0125] Furthermore, Table 6 shows that when acetophenone is contained in the treatment solution at 20% by mass or more as the first solvent, as in treatment solutions E-1 to E-4, good results are obtained in both the evaluation of the unexposed film loss and the selectivity of the test membrane. Furthermore, comparing the results of treatment solutions E-1 to E-4, it can be seen that by adjusting the PGMEA content, the film loss in the unexposed portion of the test membrane can be selectively reduced. On the other hand, when the acetophenone content in the treatment solution is 10% by mass or less, as in treatment solutions E-5 to E-7, the results of the unexposed film loss and the selectivity of the test membrane tend to become poorer as the acetophenone content decreases.

[0126] [5. Investigation and Evaluation of Treatment Solutions (Mixed Solvents of First and Second Solvents)] The test film was developed for 60 seconds using treatment solutions F-1 to F-19 (combinations of benzyl alcohol and the second solvent) listed in Table 7 below, treatment solutions G-1 to G-6 (combinations of anisole and the second solvent) listed in Table 8 below, and treatment solutions G-7 to G-12 (combinations of acetophenone and the second solvent) listed in Table 8 below, and then rinsed for 15 seconds with 2-propanol. The film thickness change in the exposed and unexposed areas was then measured using a film thickness measuring device. Tables 7 and 8 show the (mass) ratios of solvents 1 and 2 in each treatment solution, respectively. Furthermore, the film loss and selectivity of the unexposed areas of the test film were evaluated according to the same criteria as above. The results are shown in Tables 7 and 8.

[0127]

[0128]

[0129] From Table 7, it can be seen that when the treatment solution contains 20% by mass or more of benzyl alcohol, as in treatment solutions F-1 to F-19, good results are obtained in both the evaluation of the film loss in the unexposed portion of the test film and the selectivity. Furthermore, when the results of treatment solution C-1 in Table 4 are compared with the results of treatment solutions F-1 to F-19 in Table 7, it can be seen that by mixing a second solvent in addition to benzyl alcohol, it is possible to more selectively reduce the film loss in the unexposed portion of the test film.

[0130] Furthermore, Table 8 shows that when the treatment solution contains 20% by mass or more of anisole, as in treatment solutions G-1 to G-6, or when the treatment solution contains 20% by mass or more of acetophenone, as in treatment solutions G-7 to G-12, good results are obtained in both the evaluation of the film loss in the unexposed portion of the test film and the selectivity. From the results of treatment solutions G-1 to G-12, it can be seen that by appropriately adjusting the second solvent to be combined with the first solvent, it is possible to improve the film loss in the unexposed portion of the test film and the selectivity.

Claims

1. A pattern formation method comprising the steps of exposing a metal compound-containing film to light and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid contains 20% by mass or more of a first solvent which is one or more solvents selected from the group consisting of: (1) a benzene ring in which one or more hydrogen atoms are substituted with a polar substituent; (2) a 5- or 6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent; (3) a 5- or 6-membered hydrocarbon ring having one or more double bonds in the ring and at least one of the hydrogen atoms being substituted with a polar substituent, or having a carbonyl group in the ring and at least one of the hydrogen atoms being substituted with a polar substituent; and (4) a 5- or 6-membered non-aromatic heterocycle in which at least one of the hydrogen atoms is substituted with a polar substituent, or having a total of two or more heteroatoms or carbonyl groups in the ring and at least one of the hydrogen atoms being substituted with a polar substituent.

2. A pattern forming method comprising the steps of forming a metal compound-containing film using a metal compound-containing film-forming composition, exposing the metal compound-containing film, and treating the exposed metal compound-containing film with a treatment liquid, wherein the treatment liquid is selected from the group consisting of: (1) a benzene ring having one or more hydrogen atoms substituted with a polar substituent; (2) a 5- or 6-membered aromatic heterocycle having one or more hydrogen atoms optionally substituted with a polar substituent; (3) a 5- or 6-membered hydrocarbon ring having one or more double bonds in the ring and at least one or more hydrogen atoms optionally substituted with a polar substituent, or having a carbonyl group in the ring and at least one or more hydrogen atoms optionally substituted with a polar substituent; and (4) a 5- or 6-membered non-aromatic heterocycle having at least one hydrogen atom substituted with a polar substituent, or having a total of two or more heteroatoms or carbonyl groups in the ring and at least one or more hydrogen atoms optionally substituted with a polar substituent.

5. A pattern forming method comprising the steps of:

3. The pattern formation method according to claim 1, wherein the treatment liquid further contains 1 to 80 mass % of a second solvent different from the first solvent.

4. The pattern formation method according to claim 3, wherein the second solvent is one or more solvents selected from the group consisting of ketone-based solvents, ester-based solvents, alcohol-based solvents, amide-based solvents, ether-based solvents, hydrocarbon-based solvents and water.

5. The pattern forming method according to claim 1, wherein the metal compound-containing film is a metal compound-containing film containing a metal element of Groups 3 to 7.

6. The pattern forming method according to claim 1, wherein the metal compound is a polyoxometalate.

7. The pattern formation method according to claim 6, wherein the polyoxometalate is a polyoxomolybdate, a polyoxotungstate, a polyoxovanadate, a polyoxoniobate, or a polyoxotantalate.

8. The pattern forming method according to claim 6, wherein the polyoxometalate is an onium salt.

9. The pattern forming method according to claim 8, wherein the onium salt is an ammonium salt, a sulfonium salt, or an iodonium salt.

10. The pattern forming method according to claim 1, wherein the exposing step is a step of exposing with EUV or an electron beam.

11. A treatment solution for a metal compound-containing film, comprising 20% ​​by mass or more of a first solvent which is one or more solvents selected from the group consisting of: (1) a benzene ring in which one or more hydrogen atoms are substituted with a polar substituent; (2) a 5- or 6-membered aromatic heterocycle in which one or more hydrogen atoms may be substituted with a polar substituent; (3) a 5- or 6-membered hydrocarbon ring having one or more double bonds in the ring and at least one of the hydrogen atoms being substituted with a polar substituent, or having a carbonyl group in the ring and at least one of the hydrogen atoms being substituted with a polar substituent; and (4) a 5- or 6-membered non-aromatic heterocycle in which at least one of the hydrogen atoms is substituted with a polar substituent, or having a total of two or more heteroatoms or carbonyl groups in the ring and at least one of the hydrogen atoms being substituted with a polar substituent.

12. The treatment solution for a metal compound-containing film according to claim 11, further comprising 1 to 80 mass % of a second solvent different from the first solvent.

13. The treatment solution for a metal compound-containing film according to claim 12, wherein the second solvent is one or more solvents selected from the group consisting of ketone-based solvents, ester-based solvents, alcohol-based solvents, amide-based solvents, ether-based solvents, hydrocarbon-based solvents and water.

14. The metal compound-containing film treatment liquid according to claim 11, which is a polyoxometalate-containing film treatment liquid.

Citation Information

Patent Citations

  • Photonic crystal manufacturing method

    JP2008512695A

  • Metal-organic metal chalcogenide clusters and their applications in lithography

    JP2022541818A

  • Ionic salt, and radiation-sensitive resist composition

    JP2023013561A

  • Pattern formation process

    WO2016043200A1

  • Radiation-sensitive composition and pattern formation method

    WO2017169440A1